| Primary |
| Glaucoma |
19.8% |
| Intraocular Pressure Increased |
9.9% |
| Eye Oedema |
8.6% |
| Behcet's Syndrome |
7.4% |
| Benign Intracranial Hypertension |
7.4% |
| Epilepsy |
4.9% |
| Migraine |
4.9% |
| Cataract Operation |
3.7% |
| Diabetes Mellitus |
3.7% |
| Mountain Sickness Acute |
3.7% |
| Prophylaxis |
3.7% |
| Venous Pressure |
3.7% |
| Anterior Chamber Disorder |
2.5% |
| Ataxia |
2.5% |
| Blood Cholesterol Increased |
2.5% |
| Hypertension |
2.5% |
| Intracranial Pressure Increased |
2.5% |
| Maculopathy |
2.5% |
| Polyarthritis |
2.5% |
| Abnormal Sensation In Eye |
1.2% |
|
| Renal Failure Acute |
13.9% |
| Dyspnoea |
8.3% |
| Metabolic Acidosis |
8.3% |
| Rash |
8.3% |
| Angle Closure Glaucoma |
5.6% |
| Ileus Paralytic |
5.6% |
| Nystagmus |
5.6% |
| Somnolence |
5.6% |
| Tremor |
5.6% |
| Vomiting |
5.6% |
| Abdominal Discomfort |
2.8% |
| Behcet's Syndrome |
2.8% |
| Cataract Operation Complication |
2.8% |
| Cerebellar Ataxia |
2.8% |
| Choroidal Effusion |
2.8% |
| Cyanosis |
2.8% |
| Dehydration |
2.8% |
| Disorientation |
2.8% |
| Drug Dispensing Error |
2.8% |
| Drug Toxicity |
2.8% |
|
| Secondary |
| Epilepsy |
20.4% |
| Product Used For Unknown Indication |
16.2% |
| Intraocular Pressure Increased |
9.9% |
| Drug Use For Unknown Indication |
6.6% |
| Angle Closure Glaucoma |
5.9% |
| Eye Oedema |
4.9% |
| Foetal Exposure During Pregnancy |
4.9% |
| Convulsion |
4.7% |
| Schizophrenia |
3.8% |
| Meningioma |
2.6% |
| Glaucoma |
2.4% |
| Blood Cholesterol Increased |
2.1% |
| Brain Oedema |
2.1% |
| Drug Exposure During Pregnancy |
2.1% |
| Mountain Sickness Acute |
2.1% |
| Pulmonary Oedema |
2.1% |
| Oedema |
1.7% |
| Open Angle Glaucoma |
1.7% |
| Polyarthritis |
1.7% |
| Preoperative Care |
1.7% |
|
| Foetal Exposure During Pregnancy |
14.7% |
| Drug Ineffective |
9.2% |
| Speech Disorder |
9.2% |
| Intraocular Pressure Increased |
6.4% |
| Meningioma |
5.5% |
| Pericardial Haemorrhage |
5.5% |
| Acute Generalised Exanthematous Pustulosis |
4.6% |
| Grand Mal Convulsion |
4.6% |
| Off Label Use |
4.6% |
| Somnolence |
4.6% |
| Vision Blurred |
4.6% |
| Conjunctivitis |
3.7% |
| Visual Impairment |
3.7% |
| Intra-uterine Death |
2.8% |
| Nervousness |
2.8% |
| Pancytopenia |
2.8% |
| Postpartum Haemorrhage |
2.8% |
| Pregnancy |
2.8% |
| Psychiatric Symptom |
2.8% |
| Renal Failure Acute |
2.8% |
|
| Concomitant |
| Product Used For Unknown Indication |
45.2% |
| Drug Use For Unknown Indication |
23.0% |
| Prophylaxis |
5.7% |
| Depression |
3.0% |
| Hypertension |
2.5% |
| Acute Lymphocytic Leukaemia |
2.2% |
| Hiv Infection |
2.0% |
| Epilepsy |
1.7% |
| Gastrooesophageal Reflux Disease |
1.7% |
| Behcet's Syndrome |
1.5% |
| Rheumatoid Arthritis |
1.4% |
| Chronic Obstructive Pulmonary Disease |
1.4% |
| Glaucoma |
1.3% |
| Constipation |
1.2% |
| Pain |
1.2% |
| Infantile Spasms |
1.1% |
| Multiple Sclerosis |
1.0% |
| Premedication |
1.0% |
| Irritable Bowel Syndrome |
0.9% |
| Asthma |
0.9% |
|
| Suicidal Ideation |
11.6% |
| Vomiting |
9.3% |
| Drug Resistance |
8.7% |
| Visual Acuity Reduced |
8.7% |
| Weight Decreased |
7.6% |
| Convulsion |
4.7% |
| Weight Increased |
4.7% |
| Headache |
4.1% |
| Pain |
4.1% |
| Pancreatitis |
4.1% |
| White Blood Cell Count Decreased |
4.1% |
| Death |
3.5% |
| Drug Ineffective |
3.5% |
| Thrombosis |
3.5% |
| Toxic Anterior Segment Syndrome |
3.5% |
| Calcium Deficiency |
2.9% |
| Cerebral Infarction |
2.9% |
| Cerebrovascular Accident |
2.9% |
| Glaucoma |
2.9% |
| Intraocular Pressure Increased |
2.9% |
|
| Interacting |
| Glaucoma |
33.3% |
| Renal Transplant |
33.3% |
| Gastroduodenitis |
11.1% |
| Hyperuricaemia |
11.1% |
| Immunosuppression |
11.1% |
|
|
